PlainRecalls
FDA Drug Low Class III Terminated

WAL-DRAM 2 (meclizine Hydrochloride) 25 mg tablets, packaged in a) 12 count (NDC 0363-1407-01, UPC 3 11917-18328 2 ) and b) 18-count boxes (NDC 0363-1407-02, UPC 3 11917-20318 8) Distributed by Sato Pharmaceutical INC. 20695 S. Western Ave., Suite 240 Torrence, CA 90501,

Reported: November 20, 2019 Initiated: October 1, 2019 #D-0324-2020

Product Description

WAL-DRAM 2 (meclizine Hydrochloride) 25 mg tablets, packaged in a) 12 count (NDC 0363-1407-01, UPC 3 11917-18328 2 ) and b) 18-count boxes (NDC 0363-1407-02, UPC 3 11917-20318 8) Distributed by Sato Pharmaceutical INC. 20695 S. Western Ave., Suite 240 Torrence, CA 90501,

Reason for Recall

Subpotent Drug

Details

Recalling Firm
Sato Pharmaceutical Inc.
Units Affected
a) 112,104 units b) 24,696 units
Distribution
Nationwide within the United States, Guam and Saipan
Location
Torrance, CA

Frequently Asked Questions

What product was recalled?
WAL-DRAM 2 (meclizine Hydrochloride) 25 mg tablets, packaged in a) 12 count (NDC 0363-1407-01, UPC 3 11917-18328 2 ) and b) 18-count boxes (NDC 0363-1407-02, UPC 3 11917-20318 8) Distributed by Sato Pharmaceutical INC. 20695 S. Western Ave., Suite 240 Torrence, CA 90501,. Recalled by Sato Pharmaceutical Inc.. Units affected: a) 112,104 units b) 24,696 units.
Why was this product recalled?
Subpotent Drug
Which agency issued this recall?
This recall was issued by the FDA Drug on November 20, 2019. Severity: Low. Recall number: D-0324-2020.